Source link : https://newshealth.biz/health-news/post-induction-ponatinib-yields-molecular-response/
In the treatment of newly diagnosed Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL), patients who fail to achieve initial molecular response with the third-generation tyrosine kinase inhibitor (TKI) ponatinib following induction can nevertheless go on to achieve minimal residual disease (MRD) negativity — and at higher rates than the earlier generation TKI imatinib. “These results […]
The post Post-Induction, Ponatinib Yields Molecular Response first appeared on News Health.
—-
Author : News Health
Publish date : 2025-05-31 19:39:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8